Services on Demand
Journal
Article
Spanish (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO
Related links
Similars in
SciELO
Share
Permalink
Memorias del Instituto de Investigaciones en Ciencias de la Salud
On-line version ISSN 1812-9528
Abstract
VILLAGRA-CARRON, Verónica et al. Distribution of oncogenic high-risk human papillomavirus and other sexually transmitted infections in Paraguayan women with and without human immunodeficiency virus. Mem. Inst. Investig. Cienc. Salud [online]. 2022, vol.20, n.3, pp.134-141. ISSN 1812-9528. https://doi.org/10.18004/mem.iics/1812-9528/2022.020.03.134.
High-risk human papillomavirus (HPV-HR) is a necessary but not sufficient cause for cervical cancer (CC). Women carriers of human immunodeficiency virus (HIV) present an increased risk for the development of cervical cancer precursor lesions, therefore, the objective of the present prospective cross-sectional study was to determine the frequency of HPV-HR and other sexually transmitted infections-STIs (condylomas, syphilis, herpes simplex virus, gonorrhoea, cytomegalovirus, hepatitis B) in 218 women with and without HIV who attended the Ministry of Health from July 2017 to March 2021. It was found that 16/54 (29.6%) HIV-positive women had HPV infection compared to 41/164 (25%) HIV-negative women (p>0.05). In relation to age, HIV-positive women had a comparable frequency of HPV infection (<30 years: 27.3% vs >30 years 30.2%), unlike HIV-negative women whom above 30 years of age presented a significant decrease in HPV-AR infection (<30 years: 33.8% vs >30 years 18.8%, p:0.028). This could be explained by the immunosuppression observed in HIV-positive women which could favour persistent infections, suggesting that they should be controlled more closely. In addition, other STIs were observed to be more frequent in HIV-positive women (29.6% vs 15.8%, p:0.026), which suggests that apart from closer monitoring, it is essential to strengthen education on risk factors for STIs, especially HPV and HIV, as well as the implementation of primary prevention by vaccination against HPV.
Keywords : sexually transmitted disease (STD); high-risk oncogenic human papillomavirus (HPV-HR); human immunodeficiency virus (HIV).
